Literature DB >> 28364175

Evaluation of radiological risk during coronary angioplasty procedures: comparison of transradial and transfemoral approaches.

Piotr Iwachow1, Izabela Miechowicz2, Piotr Kałmucki1,2, Beata Dziki1, Andrzej Szyszka1,2, Artur Baszko1,2, Tomasz Siminiak3,4.   

Abstract

Increasing operator experience and newer available interventional cardiology devices require reassessment of radiological risk related to percutaneous coronary interventions (PCI). We aimed at comparison of radiological risk and procedural data of PCIs performed by radial (RA) and femoral (FA) approach in real life patients. Detailed retrospective analysis of 1500 consecutive PCIs with the use of radial or femoral access was performed. Comparison between RA and FA groups included procedural time (PT), fluoroscopy time (FT), radiation dose and contrast volume usage. There was no significant differences between RA and FA procedures in FT (12.6 ± 13.5 vs. 11.7 ± 9.5 min), X-ray dose generated during PCI (805.9 ± 615.9 vs. 792.2 ± 633.9 mGy) and use of contrast medium (145.2 ± 62.2 vs. 152.5 ± 64.2 ml). Mean total PT was shorter in RA (43.7 ± 24.5 min) than in FA group (47.2 ± 30.13 min, p < 0.02). Patients' age positively correlated with FT (r = 0.14, p < 0.05) and PT (r = 0.07, p < 0.05) in RA but not in FA group (r = 0.05; r = -0.06, respectively). Despite younger age, PCIs in males needed higher usage of contrast medium (151.7 ± 69.2 vs. 139.1 ± 49.3 ml; p < 0.001), and higher X-ray dose (887.0 ± 660.4 vs. 657.8 ± 515.2 mGy; p < 0.001). Age significantly correlated with PT only in female (r = 0.093, p < 0.05) but not in male patients (r = 0.015). We conclude that fluoroscopy times, X-ray dose and use of contrast medium were similar in RA and FA, but mean total procedural time was significantly shorter in RA than in FA group. However, older patients in RA group needed longer fluoroscopy and procedural times to complete PCI and this was not seen in FA.

Entities:  

Keywords:  Coronary angioplasty; Femoral approach; Radial approach; X-ray dose

Mesh:

Substances:

Year:  2017        PMID: 28364175     DOI: 10.1007/s10554-017-1130-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

1.  Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial.

Authors:  Philippe Généreux; Roxana Mehran; Tullio Palmerini; Adriano Caixeta; Ajay J Kirtane; Alexandra J Lansky; Bruce R Brodie; Bernhard Witzenbichler; Martin Mockel; Giulio Guagliumi; Jan Z Peruga; Dariusz Dudek; Martin P Fahy; George Dangas; Gregg W Stone
Journal:  EuroIntervention       Date:  2011-12       Impact factor: 6.534

2.  Effect of Vascular Access Site Choice on Radiation Exposure During Coronary Angiography: The REVERE Trial (Randomized Evaluation of Vascular Entry Site and Radiation Exposure).

Authors:  Samir B Pancholy; Pankaj Joshi; Sanjay Shah; Sunil V Rao; Olivier F Bertrand; Tejas M Patel
Journal:  JACC Cardiovasc Interv       Date:  2015-07-22       Impact factor: 11.195

3.  Transradial coronary stenting: comparison with femoral access closed with an arterial suture device.

Authors:  T Mann; P A Cowper; E D Peterson; G Cubeddu; J Bowen; L Giron; W J Cantor; W N Newman; J E Schneider; R L Jobe; M J Zellinger; G C Rose
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

4.  X-ray dose to the skin in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  R Miralbell; P A Doriot; P Nouet; M Rouzaud
Journal:  Catheter Cardiovasc Interv       Date:  2000-07       Impact factor: 2.692

5.  Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study.

Authors:  Alessandro Sciahbasi; Enrico Romagnoli; Francesco Burzotta; Carlo Trani; Alessandro Sarandrea; Francesco Summaria; Gianluca Pendenza; Antonella Tommasino; Roberto Patrizi; Mario Mazzari; Rocco Mongiardo; Ernesto Lioy
Journal:  Am Heart J       Date:  2011-01       Impact factor: 4.749

6.  Comparison of radiation dose and the effect of operator experience in femoral and radial arterial access for coronary procedures.

Authors:  Johanne Neill; Hannah Douglas; Geoffrey Richardson; Eng-Wooi Chew; Simon Walsh; Colm Hanratty; Niall Herity
Journal:  Am J Cardiol       Date:  2010-08-11       Impact factor: 2.778

7.  Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician.

Authors:  Kenneth A Fetterly; Ryan J Lennon; Malcolm R Bell; David R Holmes; Charanjit S Rihal
Journal:  JACC Cardiovasc Interv       Date:  2011-03       Impact factor: 11.195

8.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Authors:  Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S Lewis; Alvaro Avezum; Philippe Gabriel Steg; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta
Journal:  Lancet       Date:  2011-04-04       Impact factor: 79.321

9.  Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery.

Authors:  S L Hetherington; Z Adam; R Morley; M A de Belder; J A Hall; D F Muir; A G C Sutton; N Swanson; R A Wright
Journal:  Heart       Date:  2009-07-12       Impact factor: 5.994

10.  Learning curve in the use of the radial artery as vascular access in the performance of percutaneous transluminal coronary angioplasty.

Authors:  S L Goldberg; R Renslo; R Sinow; W J French
Journal:  Cathet Cardiovasc Diagn       Date:  1998-06
View more
  1 in total

1.  Cardiovascular imaging 2017 in the International Journal of Cardiovascular Imaging.

Authors:  Johan H C Reiber; Amer Alaiti; Hiram G Bezerra; Johan De Sutter; Paul Schoenhagen; Arthur E Stillman; Nico R L Van de Veire
Journal:  Int J Cardiovasc Imaging       Date:  2018-06       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.